Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

The objective of this study was to compare MRI response assessment with metabolic O-(2-
18F-fluoroethyl)-l-tyrosine (18F-FET) PET response evaluation during antiangiogenic …

To date, the use of structural MR imaging (including contrast-enhanced and T2-weighted or
fluid-attenuated inversion recovery–weighted images) is the standard method to diagnose …

With the dismal prognosis for malignant glioma patients, survival predictions become key
elements in patient management. This study compares the value of 3′-deoxy-3′-18F …

Purpose: This study compares the value of 3, 4-dihydroxy-6-[18F]-fluoro-l-phenylalanine
(18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …

Purpose Evaluation of treatment effects in malignant brain tumors is challenging because of
the lack of reliable response predictors of tumor response. This study examines the …

Background The goal of this prospective study was to compare the value of both
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …

Prognosis of recurrent high-grade glioma (HGG) is poor, although bevacizumab has been
documented in that context. This study aimed to determine the independent prognostic value …

Background Diagnostic accuracy in previous studies of O-(2-[18F]-fluoroethyl)-L-tyrosine
(18F-FET) PET in patients with suspected recurrent glioma may be influenced by prolonged …

The current study examined the use of voxel-wise changes in 18F-FDOPA and 18F-FLT PET
uptake, referred to as parametric response maps (PRMs), to determine whether they were …